GlobeNewswire 18/11/2025 Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
GlobeNewswire 18/11/2025 Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Offic...
GlobeNewswire 17/11/2025 Immatics Announces Third Quarter 2025 Financial Results and Business Update
GlobeNewswire 13/11/2025 CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
GlobeNewswire 12/11/2025 Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
GlobeNewswire 12/11/2025 Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
GlobeNewswire 12/11/2025 ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Followin...
GlobeNewswire 12/11/2025 Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire 12/11/2025 TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 11/11/2025 Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritizat...
GlobeNewswire 10/11/2025 Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board o...
GlobeNewswire 07/11/2025 ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 06/11/2025 CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 06/11/2025 Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
GlobeNewswire 06/11/2025 Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire 06/11/2025 Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
TeleTrader 05/11/2025 US closes higher ahead of major tech earnings
GlobeNewswire 05/11/2025 Royalty Pharma Reports Third Quarter 2025 Results
TeleTrader 04/11/2025 Amgen Q3 revenue jumps 12% to $9.6 billion
GlobeNewswire 04/11/2025 CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunoth...
TeleTrader 04/11/2025 US futures down ahead of busy earnings day
GlobeNewswire 03/11/2025 TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Stra...
GlobeNewswire 03/11/2025 AAVantgarde Closes $141 Million Series B Financing to Advance its Clinical Programs in Stargardt Dis...
GlobeNewswire 30/10/2025 Ligand to Participate in November Investor Conferences
GlobeNewswire 30/10/2025 CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025